FDA Commissioner Marty Makary Resigns Amid Dispute Over Flavored Vape Approvals

Marty Makary has resigned from his position as Commissioner of the U.S. Food and Drug Administration (FDA) following a significant policy disagreement with President Donald Trump regarding the approval of flavored e-cigarettes. The departure highlights a sharp clash within the administration over public health regulations and the vaping industry. Makary's resignation creates a leadership vacuum at the agency, with Kyle Diamantas appointed to serve as the acting commissioner until a permanent replacement is confirmed. This event underscores the ongoing tension between regulatory bodies and political leadership concerning tobacco and vaping products, which have been subject to intense scrutiny due to health concerns, particularly among youth. The decision to resign rather than compromise on the approval process suggests deep ideological or procedural divides within the executive branch's approach to consumer health safety. The incident draws attention to the influence of political pressure on scientific and regulatory decisions within federal agencies, raising questions about the autonomy of health officials in the current administrative landscape.